Essity’s net sales decreased 8.2% in the fourth quarter of 2025 compared with the corresponding period a year ago and amounted to SEK 34.7 billion ($3.8 billion). Excluding currency translation effects, net sales decreased SEK 400 million ($43.9 million).

Organic sales decreased 1.1%, mainly due to lower sales prices in Consumer Goods and Professional Hygiene. Volumes were relatively stable for the group as favorable volume growth in Health & Medical largely offset lower volumes in Consumer Goods and Professional Hygiene. The product mix was unchanged.

Growth was negative in Europe due to lower sales in Consumer Goods related to Consumer Tissue and Baby Care. Growth was also negative in North America, mainly as a result of lower sales in Professional Hygiene. In Latin America, growth was high, with good growth in Consumer Goods and Professional Hygiene.

In the Health & Medical segment, Q4 net sales increased organically 0.7% as a result of higher volumes. Growth was positive in North America and stable in Europe. In Latin America and Asia, growth was negative.

In Incontinence Products Health Care, volumes were higher while sales prices were lower.

Organic growth in Medical Solutions was mainly driven by higher sales prices and volume growth. Growth was positive in all three therapeutic areas: wound care, compression therapy and orthopedics.

In the Consumer Goods segment, Q4 net sales decreased organically 2%, primarily driven by lower sales prices. Volumes and product mix were also somewhat lower. Growth was high in Latin America but negative in Europe and North America.

Incontinence Products Retail reported strong organic growth driven by higher volumes. The underlying growth in Feminine Care was good in the quarter, although volumes were somewhat lower in Europe. Net sales were negatively impacted by an adjustment of previously reported customer discounts in Latin America. The Baby Care market in Europe remained challenging during the quarter, and growth in Baby Care was negative. In contrast, Essity’s leading baby care brand Libero noted strong growth in the Nordic region. Growth in Consumer Tissue was negative, mainly due to lower volumes and lower prices in the private label division. Own-brand sales increased in Consumer Tissue under brands such as Tempo, Zewa, Lotus and Familia.

Market shares increased for more than 65% of branded sales, with all four categories reporting an increase.

In Professional Hygiene, Q4 net sales decreased organically 0.8%, driven by lower sales prices and volumes. Volumes were negatively affected by lower demand in the hotel and restaurant sector. The product mix remained favorable with an increased share of premium products. Growth was positive in Latin America and Europe but negative in North America.

For the full year 2025, Essity’s net sales decreased 4.8% compared with the corresponding period a year ago and amounted to SEK 138.5 billion ($15.2 billion). Sales increased organically 0.9%. All business areas reported positive organic growth. Volumes for the group were stable, with higher volumes in Consumer Goods and Health & Medical. However, volumes were lower in Professional Hygiene, mainly due to lower demand in the hotel and restaurant sector. Higher prices had a positive impact on growth, mainly driven by Professional Hygiene and Consumer Goods. The product mix was stable for the group.